26.08.20141740
После венозной тромбоэмболии ((ВТЭ) тромбоза глубоких вен или легочной эмболии) большинство пациентов принимают варфарин или новые пероральные антикоагулянты в течение 6 - 12 месяцев, после окончания терапии у таких пациентов остается риск рецидива ВТЭ.
25.08.20141896
These results call into question the JNC 8 panel recommendation to relaxsystolic BP targets to <150 mm Hg for patients aged 60 and older, according to the researchers.
22.08.20141588
Ischaemic preconditioning has well-established cardiac and vascular protective effects. Short interventions (one week) of daily ischaemic preconditioning episodes improve conduit and microcirculatory function.
22.08.20141815
The FDA has approved the oral anticoagulant drug apixaban for treating deep vein thrombosis and pulmonary embolism and for preventing recurrent episodes of these conditions, according to the two firms selling the drug.
21.08.20142587
Scientific programme endorsed by the European Association for Cardiovascular Prevention and Rehabilitation (EACPR), a registered branch of the European Society of Cardiology (ESC).
20.08.20142133
At the end of summer Committee of the World Sleep Day summarized results of the Best Event Contest dedicated to this day.
20.08.20141655
The incidence of sick sinus syndrome in the United States is projected to double in the next 50 years, with increased risk specifically in older and white adults.